LifeVantage Corp LFVN:NASDAQ (Common Stock)
| Last | Change / % Change | Dividend Yield | Volume | Avg Volume (10 day) |
|---|---|---|---|---|
| 1.17 | 0.01 0.86% | 1,019,532 | 408.0K |
Latest News Headlines for LifeVantage Corp
Video Release -- LifeVantage Launches Two Multi-Dimensional Energy Products in the United States Company Introduces New Approach to Energy Drink Market SALT LAKE CITY, Oct. 3, 2014 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), has entered the exciting new energy product category that will forever change how exhausted, over-stressed people around the world regain their edge. Unlike other one-dimensional energy products that rely almost entirely on caffeine and sugar for a temporary energy boost, both LifeVantage energy drink powders deliver sustained energy, as well as improved mental focus and promote a positive mood. All derived from a unique combination of scientifically validated ingredients.
Latest Annual and Quarterly SEC Filings
More FilingsCompany Background
Lifevantage Corporation (Lifevantage) is engaged in the identification, research, development, manufacture and distribution of advanced nutraceutical dietary supplements, including its product, Protandim, the Nrf2 Synergizer and its anti-aging skin care product, LifeVantage TrueScience. The Company focuses its ongoing internal research efforts on oxidative stress solutions, particularly the activation of nuclear factor (erythroid-derived 2)-like 2, also known as Nrf2, as it relates to health-related disorders. The Company provides products and network marketing business opportunity to customers and independent distributors. The Company sells its products in the United States, Japan, Australia and Mexico through a network of independent distributors, and to preferred and retail customers. In April 2014, the Company acquired a line of sports nutrition products known as Wicked Fast Sports Nutrition.
collapse, right-facing arrow indicating collapsed view of sectionOverview
| Bid | Size | -- | -- |
|---|---|
| Ask | Size | -- | -- |
| Price Open | 1.18 |
| Previous Close | 1.17 |
| Day High | -- |
| Day Low | -- |
| 52 Week High | 10/25/2013 | 2.62 |
| 52 Week Low | 1/31/2014 | 1.10 |
| % Off 52 Week High | -55.34% |
| % Off 52 Week Low | 6.36% |
| Beta (5 Yr) | 0.81 |
| Volatility Avg | 10/8/2014 | 49.64 |
| 10-Day Avg. Volume | 408,048 |
| Market data is delayed by at least 20 minutes. | |
collapse, right-facing arrow indicating collapsed view of sectionFundamentals
| EPS (TTM) | 6/30/2014 | 0.10 |
|---|---|
| P/E Ratio | 6/30/2014 | 11.5 |
| Market Cap | Micro Cap | 118.0M |
| Shares Outstanding | 100.82M |
| Float | 97.9M |
collapse, right-facing arrow indicating collapsed view of sectionDividends
| Dividend Yield | -- |
|---|---|
| Ex-Date | -- |
| Dividend Announcement | -- |
| Date of Record | -- |
| Payable | -- - -- |
| Payable Date | -- |
Peers Information HelpLFVN LifeVantage Corp vs. Peers
| Peers | |
|---|---|
LFVN LifeVantage Corp | -29.09% |
Johnson & Johnson | 14.54% |
Prestige Brands Holdings, Inc. | -11.73% |
Pfizer Inc. | -4.08% |
Merck & Co., Inc. | 20.24% |
LFVN LifeVantage Corp | 0.00% |
Johnson & Johnson | 2.67% |
Prestige Brands Holdings, Inc. | -- |
Pfizer Inc. | 3.54% |
Merck & Co., Inc. | 2.92% |
LFVN LifeVantage Corp | 0.86% |
Johnson & Johnson | 2.46% |
Prestige Brands Holdings, Inc. | 0.57% |
Pfizer Inc. | 2.05% |
Merck & Co., Inc. | 2.94% |